Evidence map›Paper›PMID 32274398›Full record

ArticleReports of biochemistry & molecular biology2019

Antiproliferative Activity of

Motahare-Sadat Hosseini, Fatemehsadat Hosseini, Abdolreza Ahmadi, Masoud Mozafari, Issa Amjadi

Open access · greenAbstract read
In one paragraph

Article in Reports of biochemistry & molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Polyprenylated Acylphloroglucinols fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Cytotoxic and Antioxidant Activity ofMolecules (Basel, Switzerland) · 2023
    Article
  5. TheReports of biochemistry & molecular biology · 2022
    Article
  6. Article
  7. Review
  8. Evaluation ofReports of biochemistry & molecular biology · 2021
    Article
  9. Article
  10. Antiproliferative Effects of St. John's Wort, Its Derivatives, and OtherInternational journal of molecular sciences · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Motahare-Sadat HosseiniDepartment of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran.
Fatemehsadat HosseiniFaculty of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
Abdolreza AhmadiFaculty of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
Masoud MozafariCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Issa AmjadiDepartment of Biomedical Engineering, Wayne State University, Detroit, MI, United States.
Mashhad University of Medical Sciences · IRAmirkabir University of Technology · IRIran University of Medical Sciences · IRWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, prostate cancer prevails as one of the lead cancers affecting men. Currently, prostate cancer research involves the phytochemical study of plants with anti-tumour effects. This study compares the anti-tumour effects of three plant species indigenous to Iran and their interaction with cluster of differentiation (CD)-82 protein, a therapeutic target found in prostate cancer cells.

methodsThe extracts of Hypericum perforatum, Achillea millefolium, and Aloe vera were prepared and their toxicological, cellular and gene expression responses were evaluated in PC-3 human prostate cancer cells and normal human chondrocyte cell line C28/I2. They were exposed to different concentrations of the plants (10 mg/mL, 5 mg/mL, 1 mg/mL, 100 µg/mL, 10 µg/mL, and 1 µg/mL) at three exposure time points (24, 48, 72 hours) to determine cancer cell cytotoxicity and gene expression profiles.

results: Half-maximal inhibitory concentration (IC50) in PC-3 cells ranged from 0.6 to 8.5 mg/mL for

conclusion

Indexed as

CD82Gene expressionHerbal medicineProstate cancer

Identifiers

PMID32274398
PMCPMC7103087
OpenAlexW3011670035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.